These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9272725)
1. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat. Malinowska B; Godlewski G; Bucher B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):197-202. PubMed ID: 9272725 [TBL] [Abstract][Full Text] [Related]
2. Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors. Malinowska B; Piszcz J; Koneczny B; Hryniewicz A; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):233-41. PubMed ID: 11521166 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Schlicker E; Timm J; Zentner J; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):583-9. PubMed ID: 9402037 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta. Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872 [TBL] [Abstract][Full Text] [Related]
5. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats. Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417 [TBL] [Abstract][Full Text] [Related]
6. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats. Mendiguren A; Pineda J Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566 [TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Kathmann M; Weber B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836 [TBL] [Abstract][Full Text] [Related]
8. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation. Niederhoffer N; Szabo B Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Kathmann M; Bauer U; Schlicker E; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757 [TBL] [Abstract][Full Text] [Related]
10. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Landi M; Croci T; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Manara L Eur J Pharmacol; 2002 Aug; 450(1):77-83. PubMed ID: 12176112 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Zaniewska M; McCreary AC; Przegaliński E; Filip M Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142 [TBL] [Abstract][Full Text] [Related]
13. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors. Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536 [TBL] [Abstract][Full Text] [Related]
14. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed. Pakdeechote P; Dunn WR; Ralevic V Br J Pharmacol; 2007 Nov; 152(5):725-33. PubMed ID: 17641668 [TBL] [Abstract][Full Text] [Related]
15. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor. Gouldson P; Calandra B; Legoux P; Kernéis A; Rinaldi-Carmona M; Barth F; Le Fur G; Ferrara P; Shire D Eur J Pharmacol; 2000 Jul; 401(1):17-25. PubMed ID: 10915832 [TBL] [Abstract][Full Text] [Related]
17. SR141716A is an inverse agonist at the human cannabinoid CB1 receptor. Landsman RS; Burkey TH; Consroe P; Roeske WR; Yamamura HI Eur J Pharmacol; 1997 Sep; 334(1):R1-2. PubMed ID: 9346339 [TBL] [Abstract][Full Text] [Related]
18. Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Molderings GJ; Bönisch H; Hammermann R; Göthert M; Brüss M Neurochem Int; 2002 Feb; 40(2):157-67. PubMed ID: 11738482 [TBL] [Abstract][Full Text] [Related]
19. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed. Duncan M; Kendall DA; Ralevic V J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450 [TBL] [Abstract][Full Text] [Related]
20. (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. Pertwee RG; Ross RA; Craib SJ; Thomas A Eur J Pharmacol; 2002 Dec; 456(1-3):99-106. PubMed ID: 12450575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]